{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-086256","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.582992+00:00","generated_at":"2026-05-19T08:42:26.586316+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Olema shareholders elect three Class II directors, approve say-on-pay, ratify EY","bullets":["Cynthia Butitta: 44,675,129 for, 11,733,848 withheld; Cyrus Harmon: 43,838,514 for, 12,570,463 withheld; Graham Walmsley: 44,120,432 for, 12,288,545 withheld.","Advisory vote on executive compensation: 54,057,177 for, 2,297,482 against, 54,317 abstain; broker non-votes 6,361,695.","Ratification of Ernst & Young as auditor: 62,732,079 for, 24,064 against, 14,528 abstain; no broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-086256","json":"https://secwatch.observer/filing/0000950170-25-086256.json","markdown":"https://secwatch.observer/filing/0000950170-25-086256.md","text":"https://secwatch.observer/filing/0000950170-25-086256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/0000950170-25-086256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/olma-20250610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:42:26.586316+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}